Sam Willcocks
Impact in
-
- Antibiotic Use and Resistance
- Microbiology top 5%
- Antimicrobial Peptides and Activities
Papers in
-
- Tuberculosis Research and Epidemiology 11
-
- Antimicrobial Peptides and Activities 3
- Bacterial Infections and Vaccines 3
- Co-authors
- Brendan W. Wren (19 shared papers)Ioana Diana Olaru (1 shared paper)Esther van Kleef (1 shared paper)Clare Chandler (1 shared paper)Naomi M. Fuller (1 shared paper)Christopher Finn McQuaid (1 shared paper)Quentin J. Leclerc (1 shared paper)Rebecca E. Glover (1 shared paper)
- Journals
- Frontiers in Immunology (3 papers)PLoS ONE (3 papers)Tuberculosis (2 papers)Future Microbiology (2 papers)Journal of Leukocyte Biology (2 papers)
- Partner nations
- United KingdomThailandGermany
In The Last Decade
Sam Willcocks
32 papers receiving 838 citations
Sam Willcocks's Hit Papers
Peers
Comparison fields: 5 of 72
- Applied Microbiology and Biotechnology 126
- Microbiology 102
- Molecular Medicine 89
- Infectious Diseases 175
- Immunology 107
Countries citing papers authored by Sam Willcocks
This map shows the geographic impact of Sam Willcocks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam Willcocks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam Willcocks more than expected).
Fields of papers citing papers by Sam Willcocks
This network shows the impact of papers produced by Sam Willcocks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam Willcocks. The network helps show where Sam Willcocks may publish in the future.
Co-authors
The 25 scholars most cited alongside Sam Willcocks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antimicrobial resistance and COVID-19: Intersections and implications Hit paper breakdown → | 2021 | 270 |
| 2 | 2017 | 93 | |
| 3 | 2016 | 48 | |
| 4 | 2017 | 43 | |
| 5 | 2013 | 40 | |
| 6 | 2016 | 38 | |
| 7 | 2015 | 32 | |
| 8 | 2006 | 28 | |
| 9 | 2016 | 27 | |
| 10 | 2019 | 24 | |
| 11 | 2008 | 19 | |
| 12 | 2022 | 19 | |
| 13 | 2020 | 16 | |
| 14 | 2022 | 15 | |
| 15 | 2018 | 14 | |
| 16 | 2021 | 14 | |
| 17 | 2021 | 13 | |
| 18 | 2014 | 11 | |
| 19 | 2018 | 11 | |
| 20 | 2025 | 10 |
About Sam Willcocks
Sam Willcocks is a scholar working on Infectious Diseases, Microbiology, Immunology, Molecular Medicine and Epidemiology, having authored 34 papers that have together received 858 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (11 papers), Burkholderia infections and melioidosis (5 papers), Immune Response and Inflammation (5 papers), Antimicrobial Peptides and Activities (3 papers), Bacterial Infections and Vaccines (3 papers), Antibiotic Resistance in Bacteria (3 papers), Microbial Metabolic Engineering and Bioproduction (1 paper) and Carbohydrate Chemistry and Synthesis (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (126 citations), Microbiology (102 citations), Molecular Medicine (89 citations), Infectious Diseases (175 citations) and Immunology (107 citations). Sam Willcocks has collaborated with scholars based in United Kingdom, Thailand and Germany. Frequent co-authors include Brendan W. Wren, Ioana Diana Olaru, Esther van Kleef, Clare Chandler, Naomi M. Fuller, Christopher Finn McQuaid, Quentin J. Leclerc, Rebecca E. Glover, Rumina Hasan and Gwenan M. Knight. Their work appears in journals such as Frontiers in Immunology, PLoS ONE, Tuberculosis, Future Microbiology and Journal of Leukocyte Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.